<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta charset="UTF-8" />
    <title>Legislation Document</title>
    <meta name="Generator" content="PowerTools for Open XML" />
    <style>span { white-space: pre-wrap; }
p.pt-Normal {
    text-align: center;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont {
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
span.pt-000000 {
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
table.pt-000001 {
    border-collapse: collapse;
    border: none;
    margin-left: 248.4pt;
    margin-bottom: .001pt;
}
td.pt-000002 {
    vertical-align: top;
    width: 54pt;
    border-top: none;
    border-right: none;
    padding-right: 5.4pt;
    border-bottom: none;
    border-left: none;
    padding-left: 5.4pt;
    padding-top: 0;
    padding-bottom: 0;
}
p.pt-Normal-000003 {
    font-family: 'Times New Roman', 'serif';
    font-size: 9pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000004 {
    font-family: 'Times New Roman', 'serif';
    font-size: 9pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
td.pt-000005 {
    vertical-align: top;
    width: 216pt;
    border-top: none;
    border-right: none;
    padding-right: 5.4pt;
    border-bottom: none;
    border-left: none;
    padding-left: 5.4pt;
    padding-top: 0;
    padding-bottom: 0;
}
p.pt-Normal-000006 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000007 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
p.pt-Normal-000008 {
    line-height: 200.0%;
    text-indent: 0.50in;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
p.pt-Normal-000009 {
    line-height: 200.0%;
    text-align: justify;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
p.pt-Normal-000010 {
    line-height: 150.0%;
    text-align: center;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
span.pt-DefaultParagraphFont-000011 {
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    text-decoration: underline;
    font-style: normal;
    font-weight: normal;
    margin: 0;
    padding: 0;
}
p.pt-Normal-000012 {
    text-indent: 0.50in;
    text-align: justify;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    line-height: 108%;
    margin-top: 0;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
p.pt-Normal-000013 {
    margin-top: 3pt;
    line-height: 200.0%;
    text-align: right;
    font-family: 'Times New Roman', 'serif';
    font-size: 10pt;
    margin-left: 0;
    margin-right: 0;
    margin-bottom: .001pt;
}
</style>
  </head>
  <body>
    <div>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont">
          <img src="\Content\images\embedded\image002.jpg" />
        </span>
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <div align="left">
        <table dir="ltr" class="pt-000001">
          <tr>
            <td class="pt-000002">
              <p dir="ltr" class="pt-Normal-000003">
                <span xml:space="preserve" class="pt-DefaultParagraphFont-000004">SPONSOR:  </span>
              </p>
            </td>
            <td class="pt-000005">
              <p dir="ltr" class="pt-Normal-000003">
                <span class="pt-DefaultParagraphFont-000004">Sen.Â Walsh &amp; Rep.Â Phillips</span>
              </p>
            </td>
          </tr>
          <tr>
            <td class="pt-000005">
              <p dir="ltr" class="pt-Normal-000003">
                <span class="pt-DefaultParagraphFont-000004">Sens. Hansen, Hoffner, Mantzavinos, Sokola; Rep. K.Â Johnson</span>
              </p>
            </td>
          </tr>
        </table>
      </div>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont-000007">DELAWARE STATE SENATE</span>
      </p>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont-000007">153rd GENERAL ASSEMBLY</span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <p dir="ltr" class="pt-Normal">
        <span class="pt-DefaultParagraphFont-000007">SENATE CONCURRENT RESOLUTION NO. 104</span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span class="pt-DefaultParagraphFont-000007">RECOGNIZING THE MONTH OF JUNE 2025 AS MYASTHENIA GRAVIS AWARENESS MONTH IN THE STATE OF DELAWARE.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000006">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
    </div>
    <div>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, myasthenia gravis is a neuromuscular disorder primarily characterized by muscle weakness and muscle fatigue; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, myasthenia gravis is the most common primary disorder of neuromuscular transmission; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, myasthenia gravis is caused by an abnormal immune reaction in which the bodyâs immune defenses inappropriately attack certain receptors in muscles that receive nerve impulses; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, symptoms of myasthenia gravis include eyelid drooping, double vision, weakness of the face, difficulty chewing and swallowing, and weakness of the limbs; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, severe symptoms of myasthenia gravis include weakness of the diaphragm which can cause severe difficulty breathing, which can lead to myasthenic crisis; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, myasthenic crisis is a complication of myasthenia gravis characterized by worsening of muscle weakness, resulting in respiratory failure that requires intubation and mechanical ventilation; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, the prevalence of myasthenia gravis in the United States is estimated at approximately 36,000 to 60,000 cases; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, myasthenia gravis remains underdiagnosed and the prevalence is probably higher; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, increasing public awareness of myasthenia gravis and its symptoms is an important element in promoting early detection; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, the Muscle Movement Foundation has played an integral role in advocating for and supporting those with myasthenia gravis and other neuromuscular diseases; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, the Muscle Movement Foundation has utilized the phrase âMG canât stop meâ to inspire those with myasthenia gravis and to raise awareness; and</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">WHEREAS, the color teal is associated with myasthenia gravis awareness.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">NOW, THEREFORE:</span>
      </p>
      <p dir="ltr" class="pt-Normal-000008">
        <span class="pt-DefaultParagraphFont-000007">BE IT RESOLVED by the Senate of the 153rd General Assembly of the State of Delaware, the House of Representatives concurring therein, that the General Assembly recognizes the month of June 2025 as Myasthenia Gravis Awareness Month.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000009">
        <span xml:space="preserve" class="pt-000000"> </span>
      </p>
    </div>
    <div>
      <p dir="ltr" class="pt-Normal-000010">
        <span class="pt-DefaultParagraphFont-000011">SYNOPSIS</span>
      </p>
      <p dir="ltr" class="pt-Normal-000012">
        <span class="pt-DefaultParagraphFont-000007">This Concurrent Resolution recognizes the month of June 2025 as Myasthenia Gravis Awareness Month in the State of Delaware.</span>
      </p>
      <p dir="ltr" class="pt-Normal-000013">
        <span class="pt-DefaultParagraphFont-000007">Author: Senator Walsh</span>
      </p>
    </div>
  </body>
</html>